GI Cell, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies (NCT05880043) | GI Cell, Inc. | 2023-04-28 |
Track GI Cell, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.